213 related articles for article (PubMed ID: 31710708)
1. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.
Bogaert DJ; Laureys G; Naesens L; Mazure D; De Bruyne M; Hsu AP; Bordon V; Wouters E; Tavernier SJ; Lambrecht BN; De Baere E; Haerynck F; Kerre T
Br J Haematol; 2020 Mar; 188(5):768-773. PubMed ID: 31710708
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.
Simonis A; Fux M; Nair G; Mueller NJ; Haralambieva E; Pabst T; Pachlopnik Schmid J; Schmidt A; Schanz U; Manz MG; Müller AMS
Ann Hematol; 2018 Oct; 97(10):1961-1973. PubMed ID: 29947977
[TBL] [Abstract][Full Text] [Related]
3. GATA2 and marrow failure.
Fabozzi F; Strocchio L; Mastronuzzi A; Merli P
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101278. PubMed ID: 34404529
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies Beyond Severe Combined Immunodeficiency.
Freeman AF
J Pediatric Infect Dis Soc; 2018 Dec; 7(suppl_2):S79-S82. PubMed ID: 30590619
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis.
van Lier YF; de Bree GJ; Jonkers RE; Roelofs JJTH; Ten Berge IJM; Rutten CE; Nur E; Kuijpers TW; Hazenberg MD; Zeerleder SS
Clin Immunol; 2020 Sep; 218():108522. PubMed ID: 32682923
[TBL] [Abstract][Full Text] [Related]
6. A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
Jørgensen SF; Buechner J; Myhre AE; Galteland E; Spetalen S; Kulseth MA; Sorte HS; Holla ØL; Lundman E; Alme C; Heier I; Flægstad T; Fløisand Y; Benneche A; Fevang B; Aukrust P; Stray-Pedersen A; Gedde-Dahl T; Nordøy I
J Clin Immunol; 2022 Feb; 42(2):404-420. PubMed ID: 34893945
[TBL] [Abstract][Full Text] [Related]
7. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
[TBL] [Abstract][Full Text] [Related]
8. Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation.
Rastogi N; Abraham RS; Chadha R; Thakkar D; Kohli S; Nivargi S; Prakash Yadav S
J Pediatr Hematol Oncol; 2018 Aug; 40(6):e383-e388. PubMed ID: 29189513
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Manifestations of GATA2 Deficiency.
Marciano BE; Olivier KN; Folio LR; Zerbe CS; Hsu AP; Freeman AF; Filie AC; Spinner MA; Sanchez LA; Lovell JP; Parta M; Cuellar-Rodriguez JM; Hickstein DD; Holland SM
Chest; 2021 Oct; 160(4):1350-1359. PubMed ID: 34089740
[TBL] [Abstract][Full Text] [Related]
10. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of GATA2 deficiency syndrome.
Calvo KR; Hickstein DD
Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
[TBL] [Abstract][Full Text] [Related]
12. Clinical developments in reduced intensity haematopoietic stem cell transplantation.
Hogan WJ; Storb R
Expert Opin Biol Ther; 2002 Oct; 2(7):703-14. PubMed ID: 12387669
[TBL] [Abstract][Full Text] [Related]
13. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
Rajput RV; Arnold DE
Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
[TBL] [Abstract][Full Text] [Related]
14. Unrelated donor haematopoietic stem cell transplantation for adult patients with haematological malignancies.
Huang H; Lai XY
Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):22-6. PubMed ID: 19494392
[TBL] [Abstract][Full Text] [Related]
15. MonoMAC Syndrome Caused by a Novel GATA2 Mutation Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation.
Moraes-Fontes MF; Caramalho Í; Hsu AP; Holland SM; Abecasis M
J Clin Immunol; 2019 Jan; 39(1):4-6. PubMed ID: 30478525
[No Abstract] [Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cell transplantation in primary immunodeficiency - conventional and emerging indications.
Slatter MA; Gennery AR
Expert Rev Clin Immunol; 2018 Feb; 14(2):103-114. PubMed ID: 29300535
[TBL] [Abstract][Full Text] [Related]
18. Haematopoietic stem cell transplantation in South Africa: Current limitations and future perspectives.
Grobbelaar S; Mercier AE; Verburgh E; Brittain D; Pepper MS
S Afr Med J; 2019 Sep; 109(8b):46-52. PubMed ID: 31662149
[TBL] [Abstract][Full Text] [Related]
19. Trends in hematopoietic stem cell transplant activity in Lebanon.
Bazarbachi A; Zahreddine A; Massoud R; El Cheikh J; Hanna C; Nasr F; Abboud M; Ibrahim A
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):315-320. PubMed ID: 28641098
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?
Pichler H; Fritsch G; König M; Daxberger H; Glogova E; Pötschger U; Breuer S; Lawitschka A; Güclü ED; Karlhuber S; Holter W; Haas OA; Lion T; Matthes-Martin S
Br J Haematol; 2016 Jun; 173(6):905-17. PubMed ID: 26996395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
